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Abstract
Background: The aim of this study was to examine the associations of tea consumption with the serum uric acid
(SUA) level, hyperuricemia (HU) and the risk of gout.
Methods: A comprehensive literature search up to June 2016, using PUBMED and EMBASE databases, was
conducted to identify the relevant observational studies that examined the associations of tea consumption with
the SUA level, HU and the risk of gout.
Results: A total of fifteen observational studies were included in this study, and nine studies were extracted for
meta-analysis. For the SUA level, seven studies were included. According to the combined weighted mean
difference (WMD), there was no significant difference between the highest and the lowest tea intake category in
terms of the SUA level (WMD = 7.41 μmol/L, 95%CI: −2.34 to 17.15; P = 0.136). In subgroup analysis including three
studies, green tea consumption was positively associated with the SUA level (WMD = 17.20 μmol/L, 95%CI: 7.00 to
27.40; P = 0.01). For the prevalence of HU, five studies were included. The overall multi-variable adjusted odds ratio
(OR) for the highest versus the lowest category of tea consumption was 0.98 (95%CI: 0.77 to 1.24; P = 0.839). For the
risk of gout, two prospective cohort studies showed that there was no relationship between tea consumption and
the risk of gout in males and females, respectively.
Conclusion: The current evidences suggest that tea consumption does not seem to be associated with the SUA
level, HU and the risk of gout. However, due to the limited number of studies, green tea consumption might be
positively associated with the SUA level. More well-designed prospective cohort studies are needed to elaborate
these issues further.
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Background
Hyperuricemia (HU) is a major cause of disability, which
has drawn increasing attention in recent decades be-
cause of its high prevalence in the global context [1–3].
HU occurs when the concentration of serum uric acid
(SUA), determined by the production and excretion of
urate, exceeds a normal standard. Epidemiological findings
have shown that around 21.4% of American adults suffer
from HU [4], while the prevalence of HU in some Asian
countries ranges from 13 to 25.8% [5–9]. Emerging data
indicated that HU can increase the risk of hypertension,
cardiovascular disease, diabetes and chronic kidney dis-
ease [10–13]. HU is also known as the precursor of gout,
the most common inflammatory arthritis in adult men
[14]. In the presence of SUA concentration above satur-
ation levels (≥410 mmol/L, 6.8 mg/dL), monosodium
urate (MSU) crystals form at physiological temperature
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and pH [15]. The host response to MSU crystals leads to
the clinical manifestations of gout, such as acute flares
and tophaceous disease [16, 17]. There are several risk fac-
tors for gout, including obesity [18], hypertension [19] and
certain aspects of diet, including the intake of alcohol [20]
and purine-rich foods [21]. However, the specific patho-
genesis of HU and gout has not yet been fully elucidated.
Both the American College of Rheumatology (ACR) and
the European League Against Rheumatism (EULAR)
guidelines for the management of gout support diet modi-
fication alongside pharmacologic interventions [22, 23].
Thus, identifying the modifiable dietary factors for HU or
gout appears to be an important step in the prevention
and management of these conditions.
Tea, derived from the leaves of the Camellia sinensis
plant, is one of the most popular beverages consumed
worldwide [24], especially in Eastern European and
Asian countries [25]. Tea contains several kinds of anti-
oxidants including flavonoid, catechin, thearubigin and
theaflavin [26]. It is noteworthy that tea is negatively as-
sociated with depression, cancer, Parkinson’s disease and
cardiovascular disease [24, 25, 27, 28]. Several studies
have reported that green tea extracts may decrease SUA
levels in animals [29–31]. Therefore, a similar effect in
humans may influence the prevalence of HU or gout,
but current research from epidemiological studies
remains unclear [32–38]. Thus, the present systematic
review and meta-analysis of observational studies aimed
at investigating the associations of tea consumption with
the SUA level, HU and the risk of gout. It was hypothe-
sized that tea consumption is inversely associated with
the SUA level, HU and the risk of gout.
Methods
Search strategy
This systematic review and meta-analysis was performed
with referencing to the Preferred Reporting Items for
Systematic review and Meta-analyses (PRISMA) state-
ment [39]. The electronic databases of PUBMED and
EMBASE were searched up to June 2016, using a series
of logic combinations of keywords and in-text words
that are related to uric acid (‘uric acid’, ‘gout’, ‘hyperurice-
mia’, ‘urate’, ‘hyperuricaemia’) and tea (‘tea’). The search
string is included in supplementary material (Additional
file 1). No language restriction was imposed. The refer-
ences of the retrieved articles and reviews were
evaluated.
Study selection
Two researchers (YZ and GHL) reviewed the titles, ab-
stracts and full texts of all retrieved studies independently.
Disagreements, if any, were resolved by discussions and
mutual-consultations. All eligible studies should meet the
following criteria: 1) observational studies (case–control,
cohort or cross-sectional study); 2) the exposure of inter-
est was tea; 3) the outcome of interest was the SUA level,
the prevalence of HU and the risk of gout. The exclusion
criteria were as follows: 1) duplicated or irrelevant articles;
2) reviews, letters, case reports or non-human studies; 3)
inaccessibility of full-text.
Data extraction
The available information and outcomes of each study
were screened by the two researchers (YZ and GHL)
independently. The data to be extracted were the first
author, year of publication, location, age, gender, sample
size, study design, exposure definition, original SUA
value, OR for HU or RR for gout, type of tea, adjust-
ments and outcomes. The primary outcome of interest
was the difference in SUA concentration between the
highest and the lowest category of tea consumption. The
secondary outcome of interest was the odds ratio (OR)
for the prevalence of HU and the relative risk (RR) for
the risk of gout, for the highest versus the lowest
category of tea consumption.
Quality assessment
The methodological quality of included studies was
evaluated in accordance with the Newcastle-Ottawa
Scale (NOS) [40], which is developed for assessing the
quality of non-randomised studies based on three broad
perspectives: the selection of study groups; the compar-
ability among different groups; and the ascertainment of
either the exposure or outcome of interest. Disagree-
ments with respect to the methodological quality of
results, if any, were resolved by discussion and mutual-
consultation.
Statistical analyses
The outcome measures investigated in this meta-analysis
were the SUA level and OR for the prevalence of HU.
The weighted mean difference (WMD) and its corre-
sponding 95% confidence interval (CI) for SUA were cal-
culated respectively. The pooled OR of HU and its
related 95%CI were also calculated. However, the pooled
RR of gout and its related 95%CI were not calculated
due to the limited number of studies (only two). Hence,
their findings [33, 35] were simply reported in this re-
sult, respectively. The most multivariable adjusted OR
values reported in the original study were extracted for
calculation if more than one was reported. The homogen-
eity of effect size across trials was tested by Q statistics
(p < 0.05 was considered heterogeneous). The random ef-
fect models were used for all the analysis. The I2 statistic,
which measures the percentage of the total variation
across studies due to heterogeneity, was also examined
(I2 < 25% was considered low heterogeneity, I2 around 50%
was considered moderate heterogeneity, I2 > 75% was
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considered high heterogeneity). Begg’s tests were per-
formed to assess the publication bias [41], and statistical
analyses were performed using STATA version 11.0 (Stata-
Corp LP, College Station, Texas). A p value equal to or less
than 0.05 was considered to be statistically significant,
unless otherwise specified.
Results
Literature search and study characteristics
The flow chart for the identification of the included
studies was presented in Fig. 1. A total of two hundred
and seventy four potentially relevant publications were
retrieved during the initial literature search. After elim-
inating eighty duplicated articles, one hundred and
ninety four articles were identified for detailed evalu-
ation. One hundred and nineteen studies were excluded
initially. Then, sixteen reviews, case reports or letters,
forty two non-human studies, and two articles without
full-text accessibility were removed [42, 43]. All of the
excluded articles are listed in Additional file 2. Eventu-
ally, ten cross-sectional, one case–control and four co-
hort studies were included in this systematic review and
meta-analysis. Eleven, five and two studies were related
to the associations of tea consumption with the SUA
level, HU and the risk of gout, respectively. Table 1 sum-
marizes the main characteristics of these fifteen included
studies. The methodological qualities of these studies
were shown in Additional file 3: Table S1 (cross-sec-
tional study), Table S2 (cohort study) and Table S3
(case–control study).
Weighted mean difference of SUA concentration between
the highest and the lowest tea intake category
Seven studies including five cross-sectional, one cohort and
one case–control studies, reported the SUA concentration
in different tea intake categories [32, 34, 36, 37, 44–46].
They originated from USA, China (two studies), Taiwan,
Japan, Korea and Singapore. At the level of study setting,
six population-based and one hospital-based studies were
included. Since Tian only provides baseline and five year
follow-up SUA level in tea consumers and non-tea con-
sumers, the baseline data was extracted into this meta-
analysis [46]. The combined WMD suggested that there
was no significant difference in SUA between the highest
and the lowest tea intake category (WMD=7.41 μmol/L,
95%CI: −2.34 to 17.15; P = 0.136) (Fig. 2). A substantial level
of heterogeneity was observed among studies (P < 0.001,
I2 = 93%). No evidence of publication bias was observed
among the included studies according to the Begg rank-
correlation test (P = 0.917). Since Yuan’s study [45] has a
relatively small weighting and seems like a considerable
outlier (two thirds of participants were HU or gout pa-
tients), a sensitivity analysis was conducted. The results
showed that there was a moderately increase in the SUA
level for the highest versus the lowest tea intake category
(WMD= 10.08 μmol/L, 95%CI: 0.79 to 19.38; P = 0.033). A
substantial level of heterogeneity was observed among stud-
ies (P < 0.001, I2 = 92%). No evidence of publication bias
was observed among the included studies according to the
Begg rank-correlation test (P = 0.536). Three studies were
included in a subgroup analysis for green tea. The com-
bined WMD suggested that green tea consumption was
positively associated with the SUA level (WMD=
17.20 μmol/L, 95%CI: 7.00 to 27.40; P = 0.01) (Fig. 3). A
substantial level of heterogeneity was observed among
studies (P = 0.036, I2 = 70%). No evidence of publication
bias was observed among the included studies according
to the Begg rank-correlation test (P = 1.00). It is necessary
to emphasize that there were four studies with inappropri-
ate data for meta-analysis. Chang [47], Curb [48] and
Chatzistamatiou [49] only reported the correlation coeffi-
cient between tea and the SUA level. In addition, the rela-
tive data was not showed in Haldar [50]. Chang and Haldar
found that tea consumption was positively associated with
the SUA concentration; while Curb and Chatzistamatiou
reported a negative relationship between the two.
Odds ratio of HU for the highest versus the lowest tea
intake category
Five cross-sectional studies reported the OR for the
prevalence of HU [34, 36–38, 51]. They were all com-
munity population-based studies which originated from
USA, China (two studies), Korea and Singapore. The
overall multi-variable adjusted OR for the highest versus
the lowest category of tea intake showed no significant
difference (OR = 0.98, 95%CI: 0.77 to 1.24, P = 0.839)
(Fig. 4). A substantial level of heterogeneity was
observed among studies (P = 0.001, I2 = 72%). No
evidence of publication bias was observed among the
included studies according to the Begg rank-correlation
test (P = 1.00).
Fig. 1 Flow chart for the identification of the included studies
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Relative risk of gout for the highest versus the lowest tea
intake category
Only two prospective cohort studies reported the RR for
the risk of gout [33, 35]. They were both community
population-based studies which originated from USA.
Their results showed that tea consumption does not
seem to be associated with the risk of gout in males (RR
= 0.82, 95%CI: 0.38 to 1.75) and females (RR = 1.55,
95%CI: 0.98 to 2.47), respectively.
Discussion
A total of fifteen studies were included in this systematic
review and meta-analysis. Nine studies were retrieved to
examine the associations of tea consumption with the
SUA level and HU in meta-analysis. The quantitative
synthesis of these observational studies showed that
there was no significant relationship between tea con-
sumption and the SUA level or HU. However, green tea
consumption might be positively associated with the
Fig. 2 Forest plot of meta-analysis: WMD of SUA concentration between the highest and the lowest tea intake category
Fig. 3 Forest plot of meta-analysis: WMD of SUA concentration between the highest and the lowest green tea intake category
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SUA level. In addition, two prospective cohort studies
showed that tea consumption was not associated with
the risk of gout.
Recently, a meta-analysis including five randomized
controlled trials aimed to explore the influence of tea or
tea extracts on the SUA level [52]. Unfortunately, due to
the limited number of included studies and the lack of
data on bioavailability (bioavailability is the proportion
of the dose of a drug that reaches the systemic circula-
tion intact after administration by a route other than
intravenous), it failed to clarify any effective influence.
However tea extracts could increase the SUA level in
normal subjects but decrease that in HU patients [52].
This interesting phenomenon could be due to the dual
effects of polyphenols on the SUA level. Polyphenols
could decrease the production and increase the excre-
tion of uric acid (UA) [53–55], but may also prevent oxi-
dation [33–35] (UA is an antioxidant). Further studies
are therefore needed to elaborate these issues.
Although green tea and black tea are both derived
from Camellia sinensis, they are processed differently. In
the manufacturing process of green tea, fresh tea leaves
are steamed or heated immediately after harvest and re-
sult in minimal oxidation of polyphenols. Therefore, the
major polyphenols in green tea are epigallocatechin gall-
ate (EGCG). On the contrary, in the manufacturing
process of black tea, tea leaves are dried and crushed to
enhance oxidation, which generates more kinds of poly-
phenols (e.g. theaflavins and thearubigens) [52]. Some
experimental studies reported the effect of green tea ex-
tracts in decreasing the SUA level in rat or mice. Jung
[29] and Meki [30] showed that green tea extracts could
reduce the SUA level in metabolic syndrome and
rheumatoid arthritis rat models. In addition, Chen [31]
further confirmed that green tea polyphenols could
lower the SUA level in mice with HU by decreasing UA
production and enhancing UA excretion. Therefore,
green tea consumption might be negatively associated
with the SUA level, HU and the risk of gout. Although
the combined WMD suggested that there was no signifi-
cant relationship between tea consumption and the SUA
level, the majority of WMD values actually showed an
increase in SUA level for tea group. Moreover, a sensitiv-
ity analysis excluding Yuan’s study [45], showed that tea
consumption was even moderately positively associated
with the SUA level. Therefore, we speculate some var-
ieties of tea might increase the SUA level. Since only one
study specified the varieties of tea (green tea, black tea)
[36] and two studies investigated the green tea specially
[32, 46], a subgroup analysis (three studies) for green tea
was conducted. Surprisingly, their results showed that
green tea consumption was positively associated with
the SUA level. For this obvious contradiction between
experimental and epidemiological studies, several specu-
lations were listed as follow. To begin with, the reliability
of this results might be weaken since only three studies
were included for subgroup analysis. Besides, the green
tea extracts or polyphenols might decrease the SUA level
in animal model rather than in human beings. Further-
more, the components in green tea were complicated
and some neglected substance might increase the SUA
level, which ran counter to the effect of polyphenols.
Fig. 4 Forest plot of meta-analysis: Overall multi-variable adjusted OR of HU for the highest versus the lowest category of tea consumption
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Finally, polyphenols might has a dual effect on the SUA
level which depends on the SUA level itself. In another
word, tea extracts could increase the SUA level in normal
subjects but decrease that in HU patients [52], which
might partly account for the difference in WMD which
occurred as a result of the sensitivity analysis. Neverthe-
less, we did not find any associations of tea consumption
with HU or the risk of gout. More well-designed studies
with classification of different tea varieties are needed.
The strengths of the present systematic review and
meta-analysis are mainly reflected from the following as-
pects. First, this is the first systematic review and meta-
analysis aiming at the associations of tea consumption
with the SUA level, HU and the risk of gout based on
the most comprehensive literature search to date. Sec-
ond, the included studies were analyzed based on ad-
justed results and large samples. Third, this study reveals
the potential contradiction between experimental and
epidemiological studies for green tea. Limitations of the
present study should also be acknowledged. Firstly, the
substantial level of heterogeneity among various studies
might have distorted the results of this meta-analysis.
Secondly, due to the limitation of relevant literature,
only a few studies were qualified for this meta-analysis.
Thirdly, it is difficult to evaluate the classification of tea
intake. Tea consumption was mostly assessed by the
number of cups of daily intake, but the concentration of
each variety of tea and the cup size could vary greatly
among individuals. Fourthly, the definitions of outcome
and the selection of adjusted factors were not uniform.
Last but not the least, since only a small number of
studies specified the varieties of tea, some issues could
not be addressed. These limitations might weaken the
strength of this study.
Conclusion
In conclusion, the current evidences suggest that tea con-
sumption does not seem to be associated with the SUA
level, HU and the risk of gout. However, due to the limited
number of studies, green tea consumption might be posi-
tively associated with the SUA level. More well-designed
prospective cohort studies, which classify the varieties of
tea, are needed to elaborate these issues further.
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